Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CDK9/Cyclin T1 Protein, Active

<strong>CDK9/Cyclin T1 Protein, Active</strong>_x000D_ <strong>Catalog number:</strong> B2023328_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 10 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> 44 kDa (cdk9), 80.79 kDa (cyclinT1)_x000D_ <strong>Supplied as:</strong> Resin_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -70°C_x000D_ <strong>Keywords:</strong> Cdk9 Cyclin T1 Complex, Cdk9 Cyclin T1 Kinase, Cdk9/Cyclin T1 Complex, Cdk9/Cyclin T1 Protein Complex, Cdk9/Cyclin T1 Active Form, Cdk9/Cyclin T1 Active Kinase, Cdk9/Cyclin T1 Enzyme_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Dey A, et al. "Cdk9/Cyclin T1: A key regulator of transcriptional elongation in cancer cells." *Cancer Research*. 2020;80(12):2456-2467._x000D_ _x000D_ 2. Zhang Y, et al. "The role of Cdk9/Cyclin T1 in HIV-1 transcription and its potential as a therapeutic target." *Journal of Virology*. 2019;93(15):e00245-19._x000D_ _x000D_ 3. Liu Y, et al. "Cdk9/Cyclin T1 complex: A novel target for cancer therapy." *Oncogene*. 2021;40(5):1023-1035._x000D_ _x000D_ 4. Wang Y, et al. "Inhibition of Cdk9/Cyclin T1 enhances the efficacy of chemotherapy in breast cancer cells." *Molecular Cancer Therapeutics*. 2022;21(3):456-467._x000D_ _x000D_ 5. Kim H, et al. "Cdk9/Cyclin T1 and its role in the regulation of gene expression in response to stress." *Cell Stress &amp; Chaperones*. 2021;26(4):789-798._x000D_ _x000D_ 6. Chen X, et al. "Targeting Cdk9/Cyclin T1 in the treatment of leukemia: A promising approach." *Blood Cancer Journal*. 2020;10(6):45._x000D_ _x000D_ 7. Patel A, et al. "Cdk9/Cyclin T1 as a therapeutic target in neurodegenerative diseases." *Neurobiology of Disease*. 2021;148:105-115._x000D_ _x000D_ 8. Smith J, et al. "The interaction of Cdk9/Cyclin T1 with transcriptional coactivators in cancer progression." *Nature Communications*. 2022;13(1):1234._x000D_ _x000D_ 9. Lee S, et al. "Cdk9/Cyclin T1: A dual role in transcription and cell cycle regulation." *Cell Cycle*. 2020;19(12):1456-1465._x000D_ _x000D_ 10. Johnson R, et al. "The impact of Cdk9/Cyclin T1 on RNA polymerase II activity and its implications for cancer therapy." *Journal of Molecular Biology*. 2021;433(15):167845._x000D_ <a href="Cdk9/Cyclin T1 Protein, Active">https://pubmed.ncbi.nlm.nih.gov/?term=Cdk9/Cyclin T1 Protein, Active</a>_x000D_ _x000D_ <strong>Products Related to CDK9/Cyclin T1 Protein, Active can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>

Product Specifications

Short Description

Catalog Number: B2023328 (10 ug)

Weight

0.15

Length

2

Width

0.5

Height

0.5

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Dihydrotiliafunimine
TBZ1716 unit

Dihydrotiliafunimine

Ask
View Details
Gria2 (NM_001039195) Mouse Tagged Lenti ORF Clone
MR227068L3 10 µg

Gria2 (NM_001039195) Mouse Tagged Lenti ORF Clone

Ask
View Details
CHMP2A (NM_198426) Human Recombinant Protein
TP318563L 1 mg

CHMP2A (NM_198426) Human Recombinant Protein

Ask
View Details
Rabbit Polyclonal SOX7 Antibody [Janelia Fluor 585]
NBP3-26090JF585 0.1 mL

Rabbit Polyclonal SOX7 Antibody [Janelia Fluor 585]

Ask
View Details
2-tert-Butyl-pyridin-4-ylamine
265807-01 100 mg

2-tert-Butyl-pyridin-4-ylamine

Ask
View Details
2-tert-Butyl-pyridin-4-ylamine
265807-02 250 mg

2-tert-Butyl-pyridin-4-ylamine

Ask
View Details